Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C. (Q45881596)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/1932288

Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/1932288

1 reference

based on heuristic

inferred from title

1

object named as

J M Lusher

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/1932288

publication date

1 September 1991

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/1932288

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/1932288

63

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/1932288

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/1932288

138-141

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/1932288

Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group

1 reference

https://api.crossref.org/works/10.1007%2FBF01703244

21 January 2018

Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/1932288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates. International Society for Thrombosis and Hemostasis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1932288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human anti-mouse immunoglobulins in sera of patients treated chronically with monoclonal antibody-purified factor VIII.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1932288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of factor VIII inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1932288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral safety and inhibitor development associated with factor VIIIC ultra-purified from plasma in hemophiliacs previously unexposed to factor VIIIC concentrates. The Monoclate Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/1932288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virucidal treatment of clotting factor concentrates

1 reference

https://pubmed.ncbi.nlm.nih.gov/1932288

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01703244

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/1932288

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/1932288

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45881596&oldid=1407454027"